Ischemia-modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 4, 2011, Pages 255-258

  Stachowicz Stencel, Teresa ^a   Synakiewicz, Anna ^a   Owczarzak, Anna ^a   Sliwińska, Aleksandra ^a   Aleksandrowicz Wrona, Ewa ^a   Lysiak Szydowska, Wiesawa ^a   Balcerska, Anna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Children; IMA; Neuroblastoma and soft tissue sarcomas; Oxidative stress

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; ISCHEMIA MODIFIED ALBUMIN;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADOLESCENT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; ISCHEMIA; MALE; NEUROBLASTOMA; SARCOMA; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79960679454     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20469     Document Type: Article

References (24)

1. Kekec Y, Paydas S, Tuli A, Zorludemir S, Sakman G, Seydaoglu G. Antioxidant enzyme levels in cases with gastrointestinal cancer. Eur J Intern Med 2009;20:403-406.
2. Battin EE, Brumaghim JL. Antioxidant activity of sulfur and selenium: A review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys 2009;55:1-23.
3. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol 2010;28:360-367.
4. Kaya E, Keskin L, Aydogdu I, et al. Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma. J Int Med Res 2005;33:687-692.
5. Dursun H, Bilici M, Uyanik A, Okcu N, Akyuz M. Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer. J Int Med Res 2006;34:193-199.
6. Cichota LC, Moresco RN, Duarte MMMF, Paz da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal 2008;22:1-5.
7. Roy D, Quilles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006;92:113-114.
8. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of "ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
9. Kotur-Stevuljevic J, Memon L, Stefanovic A, et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007;40:181-187.
10. Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clin Biochem 2008;41:1162-1167.
11. Lippi G, Montagnana M. Ischemia-Modified Albumin in Ischemic Disorders. Ann Thorac Cardiovasc Surg 2009;15:137.
12. Senes M, Kazan N, Coskun O, Zengi O, Inan L, Yücel D. Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 2007;44:43-47.
13. Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216-220.
14. Can M, Demirtas S, Polat O, Yildiz A. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J 2006;23:537.
15. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-444.
16. Mastella AK, Moresco RN, Bisognin da Silva D, et al. Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases. Biomed Pharmacother 2009;63:762-766.
17. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-315.
18. Stachowicz-Stencel T, Synakiewicz A, Owczarzak A, et al. The antioxidant status and response to therapy in children with soft tissue sarcomas and neuroblastoma. Pediatr Blood Cancer 2011; DOI: 10.1002/pbc.23014.
19. Apple FS, Wu AH, Mair J, et al. Committee on standarization of markers of cardiac damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-824.
20. Gaze DC, Crompton L, Collinson P. Ischemia-modified albumin concentrations should be interpreted with caution in patients with low serum albumin concentrations. Med Princ Pract 2006;15:322-324.
21. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischemia-modified albumin testing: Adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-262.
22. Lee YW, Kim HJ, Cho YH, Shin HB, Choi TY, Lee YK. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta 2007;384:24-27.
23. Polk JD, Rael LT, Craun ML, Mains CW, Davis-Merritt D, Bar-Or D. Clinical utility of the cobalt-albumin binding assay in the diagnosis of the intestinal ischemia. J Trauma 2008;64:42-45.
24. Akutsu K, Matsuda H, Sasaki H, et al. A case of acute type B aortic dissection: Limited role of laboratory testing for the diagnosis of mesenteric ischemia. Ann Thorac Cardiovasc Surg 2007;13:360-364.